Confidentiality Definition Comes Closer After AbbVie Drops EMA Cases
This article was originally published in The Pink Sheet Daily
Executive Summary
AbbVie’s decision to drop two cases against the EMA is likely to boost clinical trial transparency as well as bring drug regulators and the industry closer to a joint definition of commercial confidentiality.